{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:18:58Z","timestamp":1787494738623,"version":"build-2736575974"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.micpath.2025.107781","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:44:47Z","timestamp":1748918687000},"page":"107781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["FDA-approved drugs for targeting virulence of Pseudomonas aeruginosa: A drug repurposing approach to combat multidrug resistance"],"prefix":"10.1016","volume":"206","author":[{"given":"Bharti","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5067-0641","authenticated-orcid":false,"given":"Jatin","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Rashpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Harjai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.107781_bib1","first-page":"351","article-title":"The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections","volume":"67","author":"Driscoll","year":"2007","journal-title":"Drugs (Basel)"},{"key":"10.1016\/j.micpath.2025.107781_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.micpath.2025.107781_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107781_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.imj.2023.05.003","article-title":"Pseudomonas aeruginosa: infections and novel approaches to treatment \u201cKnowing the enemy\u201d the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment","volume":"2","author":"Sathe","year":"2023","journal-title":"Infectious Medicine"},{"key":"10.1016\/j.micpath.2025.107781_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0195-6701(03)00078-1","article-title":"Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000","volume":"54","author":"Lizioli","year":"2003","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.micpath.2025.107781_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosaBacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107781_bib7","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/1462-2920.15784","article-title":"Revisiting the virulence hallmarks of Pseudomonas aeruginosa: a chronicle through the perspective of quorum sensing","volume":"24","author":"Chadha","year":"2022","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib8","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/fmb.15.48","article-title":"Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies","volume":"10","author":"El Zowalaty","year":"2015","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-018-0629-6","article-title":"Multidrug-resistant Pseudomonas infections: hard to treat, but hope on the horizon?","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2025.107781_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"C Reygaert","year":"2018","journal-title":"AIMS Microbiology"},{"key":"10.1016\/j.micpath.2025.107781_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/jmm.0.009142-0","article-title":"Pseudomonas aeruginosa \u2013 a phenomenon of bacterial resistance","volume":"58","author":"Strateva","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib12","doi-asserted-by":"crossref","unstructured":"Patel JB, Richter SS. Mechanisms of Resistance to Antibacterial Agents. Manual of Clinical Microbiology2015. p. 1212-1245. https:\/\/doi.org\/10.1128\/9781555817381.ch69.","DOI":"10.1128\/9781555817381.ch69"},{"key":"10.1016\/j.micpath.2025.107781_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116833","article-title":"Drug repurposing against antibiotic resistant bacterial pathogens","volume":"279","author":"Aggarwal","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2025.107781_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","article-title":"Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa","volume":"11","author":"Kunz","year":"2022","journal-title":"Infectious Diseases and Therapy"},{"key":"10.1016\/j.micpath.2025.107781_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acsinfecdis.8b00112","article-title":"The therapeutic pipeline for Pseudomonas aeruginosa infections","volume":"4","author":"Burrows","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107781_bib16","series-title":"A Comprehensive Status Update on Modification of Foley Catheter to Combat Catheter-Associated Urinary Tract Infections and Microbial Biofilms","first-page":"168","author":"Chadha","year":"2024"},{"key":"10.1016\/j.micpath.2025.107781_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01296-18","article-title":"Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa","volume":"62","author":"D'Angelo","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107781_bib19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib20","series-title":"Molecular Aspects and Therapeutic Applications","article-title":"DR): an emerging approach in drug discovery. Drug repurposing - hypothesis","author":"Rudrapal","year":"2020"},{"key":"10.1016\/j.micpath.2025.107781_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","article-title":"Computational drug repositioning for rare diseases in the era of precision medicine","volume":"23","author":"Delavan","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.micpath.2025.107781_bib22","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.micpath.2025.107781_bib23","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","article-title":"Drug repurposing: a better approach for infectious disease drug discovery?","volume":"25","author":"Law","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2025.107781_bib24","doi-asserted-by":"crossref","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: Re-investigating existing drugs for new therapeutic indications","volume":"57","author":"Padhy","year":"2011","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.micpath.2025.107781_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/ETLS20160018","article-title":"Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens","volume":"1","author":"Walker","year":"2017","journal-title":"Emerging Topics in Life Sciences"},{"key":"10.1016\/j.micpath.2025.107781_bib26","author":"Newswire"},{"key":"10.1016\/j.micpath.2025.107781_bib27","author":"Presswire"},{"key":"10.1016\/j.micpath.2025.107781_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.coph.2003.04.001","article-title":"Targeting virulence for antimicrobial chemotherapy","volume":"3","author":"Lee","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.micpath.2025.107781_bib29","first-page":"61","volume":"2","author":"Marra","year":"2014"},{"key":"10.1016\/j.micpath.2025.107781_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2025.107781_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrmicro1818","article-title":"The biology and future prospects of antivirulence therapies","volume":"6","author":"Cegelski","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106730","article-title":"Beyond antibiotics: emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis","volume":"193","author":"Mudgil","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01100","article-title":"Relationship between quorum sensing and secretion systems","volume":"10","author":"Pena","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/jb.104.1.313-322.1970","article-title":"Cellular control of the synthesis and activity of the bacterial luminescent system","volume":"104","author":"Nealson","year":"1970","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2025.107781_bib35","first-page":"738","article-title":"Specificity and complexity in bacterial quorum-sensing systems","volume":"40","author":"Hawver","year":"2016","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.micpath.2025.107781_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/08927014.2016.1272104","article-title":"Quorum sensing inhibition in Pseudomonas aeruginosa biofilms: new insights through network mining","volume":"33","author":"P\u00e9rez-P\u00e9rez","year":"2017","journal-title":"Biofouling"},{"key":"10.1016\/j.micpath.2025.107781_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mib.2009.01.005","article-title":"Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules","volume":"12","author":"Williams","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijmm.2006.01.036","article-title":"A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa","volume":"296","author":"Schuster","year":"2006","journal-title":"International Journal of Medical Microbiology"},{"key":"10.1016\/j.micpath.2025.107781_bib39","doi-asserted-by":"crossref","first-page":"a012427","DOI":"10.1101\/cshperspect.a012427","article-title":"Bacterial quorum sensing: its role in virulence and possibilities for its control","volume":"2","author":"Rutherford","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.micpath.2025.107781_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrmicro.2016.89","article-title":"Quorum sensing signal\u2013response systems in Gram-negative bacteria","volume":"14","author":"Papenfort","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13238-014-0100-x","article-title":"The hierarchy quorum sensing network in Pseudomonas aeruginosa","volume":"6","author":"Lee","year":"2014","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.micpath.2025.107781_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/microorganisms10061239","article-title":"Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria","volume":"10","author":"Sionov","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.107781_bib43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/35081101","article-title":"Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase","volume":"411","author":"Dong","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2025.107781_bib44","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1128\/JB.182.24.6921-6926.2000","article-title":"Metabolism of acyl-homoserine lactone quorum-sensing signals by variovorax paradoxus","volume":"182","author":"Leadbetter","year":"2000","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2025.107781_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2958.2003.03351.x","article-title":"Acyl\u2010homoserine lactone acylase from Ralstonia strain XJ12B represents a novel and potent class of quorum\u2010quenching enzymes","volume":"47","author":"Lin","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib46","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1099\/mic.0.27961-0","article-title":"N-Acylhomoserine lactone quorum-sensing molecules are modified and degraded by Rhodococcus erythropolis W2 by both amidolytic and novel oxidoreductase activities","volume":"151","author":"Uroz","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2025.107781_bib47","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/1751-7915.13981","article-title":"Repurposing phytochemicals as anti\u2010virulent agents to attenuate quorum sensing\u2010regulated virulence factors and biofilm formation in Pseudomonas aeruginosa","volume":"15","author":"Chadha","year":"2022","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107781_bib48","doi-asserted-by":"crossref","first-page":"11633","DOI":"10.1073\/pnas.201328498","article-title":"Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa","volume":"98","author":"Calfee","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib49","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2958.2007.05840.x","article-title":"Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa","volume":"65","author":"Cugini","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.chembiol.2012.01.015","article-title":"Discovery of antagonists of PqsR, a key player in 2-Alkyl-4-quinolone-Dependent quorum sensing in Pseudomonas aeruginosa","volume":"19","author":"Lu","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.micpath.2025.107781_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biotechadv.2018.11.006","article-title":"Quorum sensing inhibitors as antipathogens: biotechnological applications","volume":"37","author":"Kalia","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.micpath.2025.107781_bib52","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1099\/mic.0.28601-0","article-title":"Quorum sensing inhibitors: a bargain of effects","volume":"152","author":"Rasmussen","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.micpath.2025.107781_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug repurposing: an effective tool in modern drug discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.micpath.2025.107781_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/AAC.4.3.306","article-title":"Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice","volume":"4","author":"Titsworth","year":"1973","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib56","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1073\/pnas.1222706110","article-title":"Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity","volume":"110","author":"Imperi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib57","article-title":"Giving drugs a second chance: antibacterial and antibiofilm effects of ciclopirox and Ribavirin against cystic fibrosis Pseudomonas aeruginosa strains","volume":"23","author":"Di","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1461-1244.2004.02380.x","article-title":"Ciclopirox: a broad\u2010spectrum antifungal with antibacterial and anti\u2010inflammatory properties","volume":"43","author":"Gupta","year":"2004","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.micpath.2025.107781_bib59","first-page":"7","article-title":"Miconazole","volume":"19","author":"Heel","year":"1980","journal-title":"Drugs (Basel)"},{"key":"10.1016\/j.micpath.2025.107781_bib60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41429-024-00731-5","article-title":"Miconazole and phenothiazine hinder the quorum sensing regulated virulence in Pseudomonas aeruginosa","volume":"77","author":"Gad","year":"2024","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2025.107781_bib61","doi-asserted-by":"crossref","DOI":"10.4314\/ahs.v16i4.29","article-title":"Glyceryl trinitrate is a novel inhibitor of quorum sensing in Pseudomonas aeruginosa","volume":"16","author":"Abbas","year":"2017","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib62","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/cbic.201900129","article-title":"Identification of the hypertension drug guanfacine as an antivirulence agent in Pseudomonas aeruginosa","volume":"20","author":"Okada","year":"2019","journal-title":"Chembiochem"},{"key":"10.1016\/j.micpath.2025.107781_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ph15020110","article-title":"Computational and biological evaluation of \u03b2-adrenoreceptor blockers as promising bacterial anti-virulence agents","volume":"15","author":"Almalki","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"21","key":"10.1016\/j.micpath.2025.107781_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113088","article-title":"Characterization of the anti-biofilm and anti-quorum sensing activities of the \u03b2-adrenoreceptor antagonist atenolol against gram-negative bacterial pathogens","volume":"23","author":"Cavalu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2025.107781_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/antibiotics11020178","article-title":"Repurposing \u03b1-adrenoreceptor blockers as promising anti-virulence agents in gram-negative bacteria","volume":"11","author":"Almalki","year":"2022","journal-title":"Antibiotics"},{"issue":"9","key":"10.1016\/j.micpath.2025.107781_bib66","first-page":"1349","article-title":"Muting bacterial communication: evaluation of prazosin anti-quorum sensing activities against gram-negative bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens","volume":"11","author":"Thabit","year":"2022","journal-title":"Biology (Basel)"},{"issue":"11","key":"10.1016\/j.micpath.2025.107781_bib67","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s00253-023-12522-3","article-title":"Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria","volume":"107","author":"Elfaky","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107781_bib68","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/biomedicines11123161","article-title":"The anti-virulence activities of the antihypertensive drug propranolol in light of its anti-quorum sensing effects against Pseudomonas aeruginosa and Serratia marcescens","volume":"11","author":"Alotaibi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2025.107781_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123161","article-title":"The anti-virulence activities of the antihypertensive drug propranolol in light of its anti-quorum sensing effects against Pseudomonas aeruginosa and Serratia marcescens","volume":"11","author":"Alotaibi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2025.107781_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.micpath.2025.107781_bib71","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.978502","article-title":"Repurposing Dimetridazole and Ribavirin to disarm Pseudomonas aeruginosa virulence by targeting the quorum sensing system","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106468","article-title":"Repurposing albendazole as a potent inhibitor of quorum sensing-regulated virulence factors in Pseudomonas aeruginosa: novel prospects of a classical drug","volume":"186","author":"Chadha","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-024-04070-y","article-title":"Revitalizing common drugs for antibacterial, quorum quenching, and antivirulence potential against Pseudomonas aeruginosa: in vitro and in silico insights","volume":"14","author":"Chadha","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.micpath.2025.107781_bib75","doi-asserted-by":"crossref","DOI":"10.4314\/ahs.v17i3.24","article-title":"Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa","volume":"17","author":"Abbas","year":"2017","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00284-020-01909-4","article-title":"Curtailing quorum sensing in Pseudomonas aeruginosa by sitagliptin","volume":"77","author":"Abbas","year":"2020","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091285","article-title":"Repurposing anti-diabetic drugs to cripple quorum sensing in Pseudomonas aeruginosa","volume":"8","author":"Hegazy","year":"2020","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.micpath.2025.107781_bib78","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/biomedicines10051169","article-title":"Anti-quorum sensing activities of gliptins against Pseudomonas aeruginosa and Staphylococcus aureus","volume":"10","author":"Khayat","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2025.107781_bib79","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-022-03302-8","article-title":"Knocking down Pseudomonas aeruginosa virulence by oral hypoglycemic metformin nano emulsion","volume":"38","author":"Gomaa","year":"2022","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107781_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106281","article-title":"Anti-virulence prospects of Metformin against Pseudomonas aeruginosa: a new dimension to a multifaceted drug","volume":"183","author":"Chadha","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11051442","article-title":"Synergistic benefits: exploring the anti-virulence effects of metformin\/vildagliptin antidiabetic combination against Pseudomonas aeruginosa via controlling quorum sensing systems","volume":"11","author":"Khayat","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2025.107781_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.micpath.2014.07.008","article-title":"Aspirin is an efficient inhibitor of quorum sensing, virulence and toxins in Pseudomonas aeruginosa","volume":"74","author":"El-Mowafy","year":"2014","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00203-019-01771-4","article-title":"An innovative role for tenoxicam as a quorum sensing inhibitor in Pseudomonas aeruginosa","volume":"202","author":"Askoura","year":"2019","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105097","article-title":"Could the analgesic drugs, paracetamol and indomethacin, function as quorum sensing inhibitors?","volume":"158","author":"Seleem","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/s00203-023-03809-0","article-title":"Diclofenac-loaded PLGA nanoparticles downregulate LasI\/R quorum sensing genes in pathogenic P. aeruginosa isolates","volume":"206","author":"Rostamnejad","year":"2024","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib86","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-023-03690-5","article-title":"In vitro and in silico assessment of anti-quorum sensing activity of Naproxen against Pseudomonas aeruginosa","volume":"39","author":"Esnaashari","year":"2023","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107781_bib87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000007224","article-title":"\u2018Subinhibitory\u2019 erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors","volume":"45","author":"Sofer","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.micpath.2025.107781_bib88","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/AAC.01230-07","article-title":"Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa","volume":"52","author":"Skindersoe","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1099\/jmm.0.025387-0","article-title":"Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections","volume":"60","author":"Bala","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib90","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s11274-013-1252-1","article-title":"Doxycycline interferes with quorum sensing-mediated virulence factors and biofilm formation in Gram-negative bacteria","volume":"29","author":"Husain","year":"2013","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107781_bib91","article-title":"Inhibition of virulence ofPseudomonas aeruginosa: a novel role of metronidazole against aerobic bacteria","volume":"8","author":"Abbas","year":"2015","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.micpath.2025.107781_bib92","doi-asserted-by":"crossref","first-page":"27952","DOI":"10.1039\/C6RA02704K","article-title":"Broad-spectrum inhibition of AHL-regulated virulence factors and biofilms by sub-inhibitory concentrations of ceftazidime","volume":"6","author":"Husain","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.micpath.2025.107781_bib93","doi-asserted-by":"crossref","DOI":"10.4314\/ahs.v17i1.25","article-title":"Quorum sensing inhibitory activity of sub-inhibitory concentrations of \u03b2-lactams","volume":"17","author":"El-Mowafy","year":"2017","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.micpath.2025.107781_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.micpath.2018.11.042","article-title":"Repositioning secnidazole as a novel virulence factors attenuating agent in Pseudomonas aeruginosa","volume":"127","author":"Saleh","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107781_bib95","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/21505594.2020.1770508","article-title":"Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE","volume":"11","author":"Baldelli","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2025.107781_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.598498","article-title":"Cephalosporins interfere with quorum sensing and improve the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.716789","article-title":"Quorum sensing inhibiting activity of cefoperazone and its metallic derivatives on Pseudomonas aeruginosa","volume":"11","author":"Naga","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib98","article-title":"Salicylic acid reduces the production of several potential virulence factors of Pseudomonas aeruginosa associated with microbial keratitis","volume":"47","author":"Bandara","year":"2006","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.micpath.2025.107781_bib99","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3762\/bjoc.14.284","article-title":"Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents","volume":"14","author":"Yuan","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.micpath.2025.107781_bib100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1099\/jmm.0.001188","article-title":"Sodium salicylate interferes with quorum-sensing-regulated virulence in chronic wound isolates of Pseudomonas aeruginosa in simulated wound fluid","volume":"69","author":"Gerner","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107781_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10111385","article-title":"A novel use of Allopurinol as A quorum-sensing inhibitor in Pseudomonas aeruginosa","volume":"10","author":"Saqr","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2025.107781_bib102","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01342-20","article-title":"New insight into vitamins E and K1 as anti-quorum-sensing agents against Pseudomonas aeruginosa","volume":"65","author":"Soltani","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2025.107781_bib103","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-024-01740-1","article-title":"Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing","volume":"14","author":"Al-Rabia","year":"2024","journal-title":"AMB Express"},{"issue":"4","key":"10.1016\/j.micpath.2025.107781_bib104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","article-title":"Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics","volume":"15","author":"Talevi","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.micpath.2025.107781_bib105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025005066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025005066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:45:42Z","timestamp":1751985942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025005066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":105,"alternative-id":["S0882401025005066"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107781","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FDA-approved drugs for targeting virulence of Pseudomonas aeruginosa: A drug repurposing approach to combat multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107781"}}